Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

Ibrahim Tora, MD, Logan Rhea, DO, Margaret Holbrook, Physician Assistant, William Ershler, MD, Yemsrach Gami, MD

Blood (2019) 134 (Supplement_1): 4880.

https://doi.org/10.1182/blood-2019-127531

Published: 2019

Journal Articles

Analysis of the Safety Profile of Direct Oral Anticoagulants Using the FDA Adverse Event Reporting System

Emma P. Deloughery, BS, Joseph J. Shatzel, MD

Blood (2018) 132 (Supplement 1): 2531.

https://doi.org/10.1182/blood-2018-99-109818

Published: 2018

Journal Articles

Analysis of the Safety Profile of Commonly Used Procoagulants Using the FDA Adverse Event Reporting System

Emma P. Deloughery, BS, Joseph J. Shatzel, MD

Blood (2018) 132 (Supplement 1): 4712.

https://doi.org/10.1182/blood-2018-99-109822

Published: 2018

Journal Articles

Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group

Tamara P. Miller, MD, Marko Kavcic, MD, Yimei Li, Todd A. Alonzo, PhD, Matt Hall, PhD, Yuan-Shung Huang, MS, Robert B. Gerbing, MA, Brian T. Fisher, DO, MSCE, Selina Luger, MD, David Rubin, MD, MSCE, Andrea Troxel, ScD, Lillian Sung, MD, PhD, Alan S. Gamis, MD, MPH, Richard Aplenc, MD, PhD

Blood (2013) 122 (21): 931.

https://doi.org/10.1182/blood.V122.21.931.931

Published: 2013

Journal Articles

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Tetsuya Tanimoto, MD, Yasuo Oshima, MD, PhD, FACP, Koichiro Yuji, M.D., Ph.D., Masahiro Kami, MD, PhD

Blood (2011) 118 (21): 1698.

https://doi.org/10.1182/blood.V118.21.1698.1698

Published: 2011

Journal Articles

Detecting Drugs That Cause Thrombocytopenia: A Comparison of Three Methods: Tests for Drug-Dependent Anti-Platelet Antibodies (DDab), Published Case Reports, and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.

Xiaoning Li, MS, Richard H. Aster, MD, Brian R. Curtis, Daniel W. Bougie, PhD, Sara K. Vesely, PhD, James N. George, MD

Blood (2007) 110 (11): 2087.

https://doi.org/10.1182/blood.V110.11.2087.2087

Published: 2007

Journal Articles

Detecting Drugs That Cause Thrombocytopenia: A Comparison of Published Case Reports and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.

Xiaoning Li, MS, Deirdra R. Terrell, MPH, James N. George, MD, Sara K. Vesely, PhD

Blood (2006) 108 (11): 462.

https://doi.org/10.1182/blood.V108.11.462.462

Published: 2006

NARROW

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

Analysis of the Safety Profile of Direct Oral Anticoagulants Using the FDA Adverse Event Reporting System

Analysis of the Safety Profile of Commonly Used Procoagulants Using the FDA Adverse Event Reporting System

Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Detecting Drugs That Cause Thrombocytopenia: A Comparison of Three Methods: Tests for Drug-Dependent Anti-Platelet Antibodies (DDab), Published Case Reports, and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.

Detecting Drugs That Cause Thrombocytopenia: A Comparison of Published Case Reports and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.

Email alerts

ASH Publications

American Society of Hematology

Lamictal® and Hemophagocytic Lymphohistiocytosis (HLH)

Analysis of the Safety Profile of Direct Oral Anticoagulants Using the FDA Adverse Event Reporting System

Analysis of the Safety Profile of Commonly Used Procoagulants Using the FDA Adverse Event Reporting System

Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children’s Oncology Group

Comparison of Adverse Drug Reactions for Patients Treated with Tyrosine Kinase Inhibitors: Data Mining of the Public Version of the FDA Adverse Event Reporting System (AERS)

Detecting Drugs That Cause Thrombocytopenia: A Comparison of Three Methods: Tests for Drug-Dependent Anti-Platelet Antibodies (DDab), Published Case Reports, and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.

Detecting Drugs That Cause Thrombocytopenia: A Comparison of Published Case Reports and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only